Global Metagenomics Sequencing Market 2022 - Industry Briefing

According to , the global metagenomics sequencing market size is expected to increase from USD 902 million in 2021 to USD 2,299 million by 2028, garnering a CAGR of 14.3% over the evaluated period.

This industry report offers market estimates of the global market, followed by a detailed analysis of the component, technology, end user, and region. The global market data on metagenomics sequencing can be segmented by component: instruments, reagents & consumables, services. The services segment was the largest contributor to the global metagenomics sequencing market in 2021. Metagenomics sequencing market is further segmented by technology: shotgun metagenomic sequencing, whole genome sequencing & de novo assembly, metatranscriptomics, 16S rRNA sequencing. According to the research, the shotgun metagenomic sequencing segment had the largest share in the global metagenomics sequencing market. Based on end user, the metagenomics sequencing market is segmented into: drug discovery, ecology & environmental metagenomics, clinical diagnostics, industrial, others. The drug discovery segment held the largest revenue share in 2021. On the basis of region, the metagenomics sequencing market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

The global metagenomics sequencing market is highly competitive. The key players in the metagenomics sequencing market include Azenta Inc. (Genewiz), BGI Group Ltd., DNAStar Inc., Eurofins Scientific SE, Illumina Inc., Macrogen Inc., Microsynth AG, Novogene Co. Ltd., Oxford Nanopore Technologies Limited, PerkinElmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Zymo Research Corporation.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
- Get a detailed picture of the Global Metagenomics Sequencing Market
- Identify segments/areas to invest in over the forecast period in the Global Metagenomics Sequencing Market
- Understand the competitive environment, the markets leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.

Part 1. Summary

Part 2. Introduction
Study period
Geographical scope
Market segmentation

Part 3. Metagenomics sequencing market overview

Part 4. Market breakdown by component
Instruments
Reagents & consumables
Services

Part 5. Market breakdown by technology
Shotgun metagenomic sequencing
Whole genome sequencing & de novo assembly
Metatranscriptomics
16S rRNA sequencing

Part 6. Market breakdown by end user
Drug discovery
Ecology & environmental metagenomics
Clinical diagnostics
Industrial
Others

Part 7. Market breakdown by region
Asia Pacific
Europe
North America
Rest of the World (RoW)

Part 8. Key companies
Azenta, Inc. (Genewiz)
BGI Group Ltd.
DNAStar, Inc.
Eurofins Scientific SE
Illumina, Inc.
Macrogen, Inc.
Microsynth AG
Novogene Co., Ltd.
Oxford Nanopore Technologies Limited
PerkinElmer, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
Zymo Research Corporation

Part 9. Methodology

Global Endocrine Function Market

This new report from provides analysis of the endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts, market shares and strategic profiles of leading suppliers.The report is

USD 14500 View Report

Global Coagulation Market Analysis

2022 Global Coagulation Market AnalysisLeading and Emerging Supplier Sales, Shares and Instrument Installed Base by Geographic Region This new report from provides granular data and analysis not available from

USD 4500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available